Funding Received
$41.5 Million in 3 Rounds from 4 Investors
Most Recent Funding
$20 Million Series C on July 2, 2013
Founded:
2008
Headquarters:
San Francisco, CA
Description:
Sequenta is engaged in the discovery and development of clinical diagnostics based on a platform for understanding immune system status.
Categories:
Biotechnology
Website:
http://www.sequenta.com/

Detailed Description

Update

Sequenta is a venture funded biotech company dedicated to the discovery and development of clinical diagnostics based on a revolutionary new platform for understanding immune system status. A profound revolution in the cost of DNA sequencing has enabled the company to develop brand new approaches to measuring the most variable part of the human genome: the immune cell receptor genes. The incredible diversity created by these genes are at the heart of a large number of conditions critical to human health and disease allowing the company to be in a position to inform a large number of clinical decisions using a single powerful assay.

The company was founded in 2008 by entrepreneurs who previously founded ParaAllele BioScience, a successful startup company sold to Affymetrix in 2005.

Current Team (2)

Update

Funding Rounds (3) - $20M

Update

Board Members and Advisors (4)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    409 Illinois Street

    San Francisco, CA 94158

    USA